Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Calgary

$135,000.00

Molecular Mechanism of Drug Blockade and Activation in Voltage-gated Potassium Channels

FY 2009-10

Summary
Ion channels are primary targets for development of therapeutic drugs for many diseases such as chronic pain, heart and muscle diseases, diabetes and epilepsy. Finding a compound that selectively target an ion channel with optimal affinity is, therefore, a primary concern for the pharmaceutical industry. However, this is usually a long and expensive task in the absence of molecular information on the molecular mechanism, underlying drug binding to the receptor. Complementing experimental results from electrophysiology, biochemical and biophysical studies with computational methods will help to rationalize this task and speed up the ligand-screening process. The aim of this project is to use simulation tools for fast and accurate screening of ligands and to investigate the binding interactions of blockers and activators with voltage-gated potassium channels involved in the drug-induced arrythmias in humans. The knowledge gathered from the analysis of ligand-homology modeled receptor interactions will be harnessed in design of new compounds that have better binding affinity properties than currently known drugs. Theoretical work will be paralleled with experimental investigations on the blockade/activation properties of top-ranked compounds.
Program
CIHR Fellowship
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
193080
Name
Durdagi Serdar
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Molecular Mechanism of Drug Blockade and Activation in Voltage-gated Potassium Channels
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cardiology; De-Novo Drug Design; In Silico Docking; Ion Channels; Membrane Biochemistry; Membranes; Molecular Dynamics (Md) Simulations; Protein-Ligand Interactions; Rational Drug Design; Structute/Function
Abstract
Ion channels are primary targets for development of therapeutic drugs for many diseases such as chronic pain, heart and muscle diseases, diabetes and epilepsy. Finding a compound that selectively target an ion channel with optimal affinity is, therefore, a primary concern for the pharmaceutical industry. However, this is usually a long and expensive task in the absence of molecular information on the molecular mechanism, underlying drug binding to the receptor. Complementing experimental results from electrophysiology, biochemical and biophysical studies with computational methods will help to rationalize this task and speed up the ligand-screening process. The aim of this project is to use simulation tools for fast and accurate screening of ligands and to investigate the binding interactions of blockers and activators with voltage-gated potassium channels involved in the drug-induced arrythmias in humans. The knowledge gathered from the analysis of ligand-homology modeled receptor interactions will be harnessed in design of new compounds that have better binding affinity properties than currently known drugs. Theoretical work will be paralleled with experimental investigations on the blockade/activation properties of top-ranked compounds.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Durdagi, Serdar
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Calgary - $135,000 Grant (2009-10) | Canada Spends